Best practices: Appropriate use of the new β-lactam/β-lactamase inhibitor combinations, ceftazidime-avibactam and ceftolozane-tazobactam in South Africa

Best practices: Appropriate use of the new β-lactam/β-lactamase inhibitor combinations, ceftazidime-avibactam and ceftolozane-tazobactam in South Africa

Antibiotic stewardship of hospital-acquired infections because of difficult-to-treat resistant (DTR) Gram-negative bacteria is a global challenge. Their increasing prevalence in South Africa has required a shift in prescribing in recent years towards colistin, an antibiotic of last resort. High toxi...

Full description

Bibliographic Details
Main Authors: Adrian J. Brink, Jennifer Coetzee, Guy A. Richards, Charles Feldman, Warren Lowman, Hafsah D. Tootla, Malcolm G.A. Miller, Abraham J. Niehaus, Sean Wasserman, Olga Perovic, Chetna N. Govind, Natalie Schellack, Marc Mendelson
Format: Article
Language:English
Published: AOSIS 2022-10-01
Series:Southern African Journal of Infectious Diseases
Subjects:
antimicrobial stewardship
β-lactam/β-lactamase inhibitor combinations
ceftazidime-avibactam
ceftolozane-tazobactam
gram-negatives
pseudomonas aeruginosa
enterobacterales
Online Access:https://sajid.co.za/index.php/sajid/article/view/453

Internet

https://sajid.co.za/index.php/sajid/article/view/453

Similar Items